LEPU BIO(02157),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02157 LEPU BIO

Trading 09-23 09:41:48

4.225

+0.020

+0.48%

High4.280	Low4.175	Vol243.00K
Open4.205	D1 Closing4.205	Amplitude2.50%
Mkt Cap7.62B	Tradable Cap7.62B	Total Shares1.80B
T/O1.03M	T/O Rate0.01%	Tradable Shares1.80B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02157","market":"HK","secType":"STK","nameCN":"LEPU BIO","latestPrice":4.225,"timestamp":1790127691654,"preClose":4.205,"halted":0,"volume":243000,"delay":0,"changeRate":0.004756242568370886,"floatShares":1804000000,"shares":1804000000,"eps":0.17434464822425802,"marketStatus":"Trading","change":0.02,"latestTime":"09-23 09:41:48","open":4.205,"high":4.28,"low":4.175,"amount":1028845,"amplitude":0.02497,"askPrice":4.245,"askSize":1000,"bidPrice":4.22,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":0.1604807142184853,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1790136000000},"marketStatusCode":2,"adr":0,"listingDate":1645545600000,"exchange":"SEHK","adjPreClose":4.205,"openAndCloseTimeList":[[1790127000000,1790136000000],[1790139600000,1790150400000]],"volumeRatio":0.737618,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02157","defaultTab":"news","newsList":[{"id":"1125223612","title":"HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125223612","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125223612?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:59","pubTimestamp":1789955946,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks rose across the board. $LEPU BIO(02157)$, $INNOCARE(09969)$ and $AKESO(09926)$ gained over 7%, while $REMEGEN(09995)$, $EVEREST MED(01952)$, $INNOVENT BIO(01801)$, $GENSCRIPT BIO(01548)$ and $SKB BIO(06990)$ rose over 6%, $3SBIO(01530)$ advanced over 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","09926","09995","01952","09969","02157","01548","01530","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668954981","title":"Chinese Healthcare Platform 111 Inc Q2 Revenue Falls 28% on Asset-Light Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2668954981","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668954981?lang=en_us&edition=fundamental","pubTime":"2026-09-17 15:12","pubTimestamp":1789629146,"startTime":"0","endTime":"0","summary":"Chinese healthcare platform 111 Inc Q2 revenue falls 28% on asset-light shiftOverviewChina healthcare platform's Q2 revenue fell 28% yr/yr amid asset-light business transitionCompany reported wider ne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL1N45907T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","YI","BK4503","BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198256689","title":"Lepu Biopharma Interim Results: Product Sales More Than Double, Revenue Up 12%, Profit Slips to RMB24.85 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1198256689","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198256689?lang=en_us&edition=fundamental","pubTime":"2026-09-16 17:08","pubTimestamp":1789549722,"startTime":"0","endTime":"0","summary":"Lepu Biopharma released its 2026 interim report showing revenue rose 12.10% year-on-year to RMB522.41 million, driven by accelerating commercial uptake of MEIYOUHENG (Becotatug Vedotin) and PUYOUHENG...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lepu Biopharma Interim Results: Product Sales More Than Double, Revenue Up 12%, Profit Slips to RMB24.85 Million","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667761606","title":"China's Lepu Biopharma H1 Revenue Rises 12.1% on Higher Drug Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2667761606","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667761606?lang=en_us&edition=fundamental","pubTime":"2026-09-16 16:42","pubTimestamp":1789548131,"startTime":"0","endTime":"0","summary":"China's Lepu Biopharma H1 revenue rises 12.1% on higher drug salesOverviewChina oncology therapeutics developer's H1 2026 revenue grew 12.1% yr/yrDomestic commercialization revenue more than doubled, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL1N45807H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU1153584641.USD","LU0784385170.HKD","LU1061106388.HKD","LU1267930813.SGD","BK5011","LU1481600234.SGD","LU1496350502.SGD","03165","LU2125909593.SGD","LU1323610961.USD","LU1355424745.HKD","LU1196032939.SGD","LU0310800379.SGD","LU0889566641.SGD","02157","LU1170363599.USD","LU2433249047.HKD","LU0499090636.EUR","LU1267930573.SGD","LU0972486137.USD","LU0640478417.SGD","LU1003076772.USD","DFTX","LU0047473722.SGD","IE00B3T34201.USD","LU0114720955.EUR","LU1301847155.USD","LU0920840948.USD","IE00BJT1NW94.SGD","LU0882574055.USD","IE00B2B36J28.USD","LU2125909247.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","AZN.UK","LU0128525689.USD","LU0128525929.USD","LU1496350171.SGD","IE0034235188.USD","LU1119994496.HKD","IE00BKPKM643.USD","LU1983299246.USD","LU2089984988.USD","LU2355687059.USD","LU0997586432.USD","LU1989772923.USD","LU0211327993.USD","LU0052756011.USD","LU0976567544.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667606919","title":"Lepu Biopharma H1 Revenue RMB 371.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2667606919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667606919?lang=en_us&edition=fundamental","pubTime":"2026-09-16 16:32","pubTimestamp":1789547552,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nPLX07KC1K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02157","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115866351","title":"HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1115866351","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115866351?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:13","pubTimestamp":1789096425,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks are experiencing sustained downward pressure in Hong Kong trading. As of the latest update, LEPU BIO (02157) has declined 3.91% to HK$38.05, while REMEGEN (09995) fell...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1008478684.HKD","LU1152091168.USD","LU0140636845.USD","LU1813983027.USD","LU2097828631.EUR","LU2097828805.USD","LU1328277881.USD","BK1191","IE0008368742.USD","09995","BK1161","BK1515","LNGR","IE00B5MMRT66.SGD","LU0315179316.USD","LU0067412154.USD","LU0149534421.HKD","LU1960683339.HKD","KCAI","LU1951186391.HKD","01801","BK1589","06978","LU0326950275.SGD","BK1574","LU0072913022.USD","LU0607220059.USD","IE00BZ08YS42.EUR","LU0463099449.HKD","LU1226288170.HKD","MEDX","PEVC","BK1583","IE00B031HY20.USD","LU2488822045.USD","MCRO","IE00BZ08YT58.USD","LU0502904849.HKD","LU1152091754.HKD","LU1969619763.USD","LU0501845795.SGD","IE00B543WZ88.USD","LU1226288253.USD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU2097828557.USD","IE0008369823.USD","SG9999004220.SGD","LU1226287792.SGD","01093","LU0455707207.USD","LU1807302812.USD","LU2097828714.EUR","LU2242644610.SGD","LU2328871848.SGD","LU2039709279.SGD","HK0000165453.HKD","LU1226287875.USD","02157","IBBQ","KURE","LU0314109678.HKD","LU1226287529.USD","LU2097828474.EUR","LU1831875114.USD","LU0244354667.USD","BK1521","VXUS","WRTH","BK4588","159992","LU0880133367.SGD","BK4585","LU1188198961.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112946006","title":"LEPU Bio Shares Jump Over 5% in Afternoon Trading on Strong H1 Revenue Growth and Upcoming Full-Cycle BD Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1112946006","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112946006?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:06","pubTimestamp":1787810812,"startTime":"0","endTime":"0","summary":"LEPU Bio (02157) saw its share price surge more than 5% during the afternoon trading session, before settling at a 3.9% gain to HK$4.13, with trading turnover reaching HK$81.11 million.The company...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4585","BK1161","BK4588","BD","KCAI","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661392202","title":"Lepu Biopharma (SEHK:2157) Stock Grapples With Profit Quality Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2661392202","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661392202?lang=en_us&edition=fundamental","pubTime":"2026-08-21 01:26","pubTimestamp":1787246819,"startTime":"0","endTime":"0","summary":"Lepu Biopharma came into today on the back foot, with the stock down about 10% over the past month, and investors clearly questioning whether the earlier move into profitability can hold. The latest half year report now forces a sentiment reset. Revenue for H1 2026 reached C¥522.4m, yet net income from core operations was only C¥27.4m, a sharp contrast with the recent trailing figures that were lifted by a C¥290.4m one off gain.\nThe market reaction looks less like cool analysis and more like...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-stock-grapples-with-profit-quality-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-stock-grapples-with-profit-quality-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02157","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660645445","title":"Lepu Biopharma FY26 H1 Profit Falls 15.2% to RMB 24.8 Million; Revenue Rises 12.1% to RMB 522.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660645445","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660645445?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:38","pubTimestamp":1787128739,"startTime":"0","endTime":"0","summary":"Lepu Biopharma FY26 H1 profit falls 15.2% to RMB 24.8 million; revenue rises 12.1% to RMB 522.4 millionLepu Biopharma posted revenue of RMB 522.4 million, up 12.1% year over year.Profit fell to RMB 24","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL3BbV0H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126980317","title":"LEPU BIO Sets 19 August 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1126980317","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126980317?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:25","pubTimestamp":1786101936,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (LEPU BIO) has notified the market that its board of directors will convene on 19 August 2026 in Shanghai. The agenda includes: • Reviewing and approving the consolidated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657106646","title":"Lepu Biopharma Sets Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2657106646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657106646?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:05","pubTimestamp":1786100759,"startTime":"0","endTime":"0","summary":"Lepu Biopharma sets board meeting to review interim results, consider dividendLepu Biopharma will hold a board meeting on Aug. 19, 2026 to review interim results for the six months ended June 30, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL1t7jp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117144688","title":"LEPU BIO Maintains 1.80 Billion Issued Shares and Confirms Public Float Compliance for July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1117144688","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117144688?lang=en_us&edition=fundamental","pubTime":"2026-08-03 17:46","pubTimestamp":1785750413,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (LEPU BIO) filed its monthly return on movements in securities for the period ended 31 July 2026, indicating that the company’s share structure remained unchanged during the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155595300","title":"Hong Kong Stock Movers: LEPU BIO Surges Nearly 4% After Positive Topline Results from Global Phase III CMG901 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1155595300","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155595300?lang=en_us&edition=fundamental","pubTime":"2026-07-28 15:34","pubTimestamp":1785224086,"startTime":"0","endTime":"0","summary":"LEPU BIO (02157) shares climbed nearly 4% in early trading, briefly surging over 12%. As of press time, the stock was up 3.83% at HK$4.61, with turnover reaching HK$91.6484 million.On July 28, the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4585","BK4134","PSYK","MDTX","02157","IBBJ","BK1161","KCAI","BMED","BK4588","III","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654078661","title":"Lepu Biopharma Reports Positive Top-Line Results from Global Phase III Trial of Cmg901 (azd0901)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654078661","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654078661?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:29","pubTimestamp":1785212978,"startTime":"0","endTime":"0","summary":"BRIEF-Lepu Biopharma Reports Positive Top-Line Results From Global Phase III Trial Of CMG901 (AZD0901)July 28 (Reuters)-Lepu Biopharma Co Ltd2157.HK:REPORTS POSITIVE TOP-LINE RESULTS FROM GLOBAL PHASE III TRIAL OF CMG901 (AZD0901)Further company coverage:2157.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654078657","title":"Lepu Biopharma Says Phase III CLARITY-Gastric01 Trial Meets Overall Survival Endpoint for Cmg901 in Late-line Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654078657","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654078657?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:28","pubTimestamp":1785212926,"startTime":"0","endTime":"0","summary":"Lepu Biopharma says Phase III CLARITY-Gastric01 trial meets overall survival endpoint for CMG901 in late-line gastric cancerLepu Biopharma reported positive top-line results from the global Phase III ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL7k2M9l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198638968","title":"LEPU BIOPHARMA Names Ren Fangyuan Employee Representative Supervisor After Zhao Lixuan Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=1198638968","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198638968?lang=en_us&edition=fundamental","pubTime":"2026-07-15 17:45","pubTimestamp":1784108728,"startTime":"0","endTime":"0","summary":"LEPU BIOPHARMA CO., LTD. announced that employee representative supervisor Zhao Lixuan resigned effective 15 July 2026 to pursue other professional engagements. Zhao confirmed no disagreements with...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166197418","title":"LEPU BIO Announces New Employee Representative Supervisor Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=1166197418","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166197418?lang=en_us&edition=fundamental","pubTime":"2026-07-15 16:58","pubTimestamp":1784105904,"startTime":"0","endTime":"0","summary":"An announcement has been issued by LEPU BIO (02157).The company's board of supervisors received a written resignation letter from its employee representative supervisor, Ms. Zhao Lixuan, on July 15,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651455955","title":"Lepu Biopharma Names Ren Fangyuan Employee Representative Supervisor, Replacing Zhao Lixuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651455955","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651455955?lang=en_us&edition=fundamental","pubTime":"2026-07-15 16:49","pubTimestamp":1784105370,"startTime":"0","endTime":"0","summary":"Lepu Biopharma names Ren Fangyuan employee representative supervisor, replacing Zhao LixuanLepu Biopharma replaced employee representative supervisor Zhao Lixuan, effective July 15, 2026.Ren Fangyuan ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL1bLRQG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193879863","title":"LEPU BIO Shares Surge Again, Gaining Over 7% on Promising Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1193879863","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193879863?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:30","pubTimestamp":1784082623,"startTime":"0","endTime":"0","summary":"Shares of LEPU BIO (02157) have surged more than 7%, extending a monthly gain of nearly 30%. At the time of writing, the stock is up 6.01% to HK$4.94, with a turnover of HK$32.62 million. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VXUS","KCAI","BK4588","02157","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649633957","title":"Lepu Biopharma (SEHK:2157) Rebound Puts Its Valuation Back In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2649633957","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649633957?lang=en_us&edition=fundamental","pubTime":"2026-07-08 09:32","pubTimestamp":1783474335,"startTime":"0","endTime":"0","summary":"Lepu Biopharma (SEHK:2157) stock has been moving without a clear headline catalyst, leaving investors to focus on its recent price swings, revenue profile and ongoing oncology drug portfolio when assessing the shares.\nSee our latest analysis for Lepu Biopharma.\nThe latest move leaves Lepu Biopharma trading at HK$4.3, after a 1 week share price return of about 11% and a 1 month gain of roughly 12%. However, the weaker 3 month and 1 year total shareholder returns indicate that momentum has been...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-rebound-puts-its-valuation-back-in-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-rebound-puts-its-valuation-back-in-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02157","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lepubiopharma.com","stockEarnings":[{"period":"1week","weight":0.0552},{"period":"1month","weight":0.0646},{"period":"3month","weight":0.1365},{"period":"6month","weight":-0.1835},{"period":"1year","weight":-0.4208},{"period":"ytd","weight":-0.1539}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":-0.0354},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.0093},{"period":"1year","weight":-0.0477},{"period":"ytd","weight":-0.0212}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Lepu Biopharma Co Ltd is a company principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The Company is focused on oncology therapeutics, in particular, targeted therapy and oncology immunotherapy. The Company is dedicated to developing innovative antibody-drug conjugate (ADC) through an ADC technology development platform. The Company’s clinical-stage drug candidates cover targeted therapeutics and an immunotherapeutic, including MRG003, MRG002, CMG901, MRG004A, CG0070, MRG006A, MRG007, and CTM012.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.070458},{"month":2,"riseRate":0.5,"avgChangeRate":0.087235},{"month":3,"riseRate":0.4,"avgChangeRate":-0.009016},{"month":4,"riseRate":0.8,"avgChangeRate":0.177486},{"month":5,"riseRate":0.4,"avgChangeRate":-0.041488},{"month":6,"riseRate":0.4,"avgChangeRate":-0.053819},{"month":7,"riseRate":0.6,"avgChangeRate":0.074049},{"month":8,"riseRate":0.6,"avgChangeRate":0.005043},{"month":9,"riseRate":0.4,"avgChangeRate":0.057995},{"month":10,"riseRate":0.25,"avgChangeRate":-0.14162},{"month":11,"riseRate":0.25,"avgChangeRate":0.007333},{"month":12,"riseRate":0.25,"avgChangeRate":-0.05091}],"exchange":"SEHK","name":"LEPU BIO","nameEN":"LEPU BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LEPU BIO(02157),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LEPU BIO(02157) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LEPU BIO,02157,LEPU BIO股票,LEPU BIO股票老虎,LEPU BIO股票老虎国际,LEPU BIO行情,LEPU BIO股票行情,LEPU BIO股价,LEPU BIO股市,LEPU BIO股票价格,LEPU BIO股票交易,LEPU BIO股票购买,LEPU BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LEPU BIO(02157),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LEPU BIO(02157) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}